As of Aug 16
| +0.05 / +0.31%|
The 6 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 21.50, with a high estimate of 24.00 and a low estimate of 18.00. The median estimate represents a +31.90% increase from the last price of 16.30.
The current consensus among 6 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.